Tsai DC, Chen HC, Leu HB, et al
Explore Microdosing GLP-1 options here
The escalation period serves a diagnostic purpose: it reveals your individual tolerance threshold and optimal therapeutic dose without the trial-and-error approach of traditional obesity medicine
It is not clear whether weight rebound consistently occurs after stopping GLP1RA agents, the time course of weight rebound, how it affects on body composition, and if this affects GWG in pregnancies complicated by obesity
Participants received once-weekly subcutaneous injections of retatrutide at varying doses or placebo over 24 weeks, with a structured dose-escalation period built into the protocol to improve tolerability
Deep hydration is achieved by combining hyaluronic acid, squalane, and beta-glucan, which create an invisible yet robust moisture barrier